Incyte Corp.

NASDAQ: INCY    
Share price (3/31/23): $72.27    
Market cap (3/31/23): $16.1 billion
Search in Documents
Key Exhibits
External Links
8 Incyte Corp. Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.1
from 10-Q 3 pages Amendment No. 3 to Global Collaboration and License Agreement
12/34/56
EX-10.1
from 10-Q 4 pages ​ Amendment No. 2 to Global Collaboration and License Agreement
12/34/56
EX-10.1
from 8-K 32 pages Incyte Corporation Amended and Restated 2010 Stock Incentive Plan (As Amended and Restated on May 13, 2021) Incyte Corporation Amended and Restated 2010 Stock Incentive Plan
12/34/56
EX-10.1
from 10-Q 3 pages Second Amendment to Collaboration and License Agreement
12/34/56
EX-10.19.1
from 10-K 3 pages First Amendment to Collaboration and License Agreement
12/34/56
EX-10.8
from 10-K 9 pages 1997 Employee Stock Purchase Plan of Incyte Corporation
12/34/56
EX-10.3
from 10-Q 7 pages Incyte Corporation Amended and Restated 2010 Stock Incentive Plan Notice of Performance Share Award
12/34/56
EX-10.2
from 10-Q 8 pages Incyte Corporation Amended and Restated 2010 Stock Incentive Plan Global Restricted Stock Unit Award Agreement
12/34/56
EX-10.1
from 10-Q 10 pages Incyte Corporation Amended and Restated 2010 Stock Incentive Plan: Global [Incentive/ Nonstatutory] Stock Option Agreement for Executive Officers ​
12/34/56
EX-10.1
from 10-Q 11 pages Material contract
12/34/56
EX-10.1
from 8-K 7 pages 1997 Employee Stock Purchase Plan of Incyte Corporation
12/34/56
EX-10.2
from 10-Q 11 pages Amendment No. 5 to Collaboration and License Agreement
12/34/56
EX-10.1
from 10-Q 197 pages Collaboration and License Agreement Recitals
12/34/56
EX-10.3
from 10-Q 20 pages Employment Agreement
12/34/56
EX-10.2.2
from 10-Q 5 pages Third Amendment
12/34/56
EX-10.2.1
from 10-Q 4 pages Amendment
12/34/56
EX-10.2
from 10-Q 162 pages Material contract
12/34/56
EX-10.1.1
from 10-Q 11 pages Amendment No. 4 to Collaboration and License Agreement
12/34/56
EX-10.1
from 10-Q 142 pages Collaboration and License Agreement by and Between Incyte Corporation Experimental Station, Route 141 & Henry Clay Road Wilmington, Delaware and Novartis International Pharmaceutical Ltd. 131 Front Street Hamilton, Bermuda Hm 12
12/34/56
EX-10.1
from 10-Q 5 pages Incyte Corporation Amended and Restated 2010 Stock Incentive Plan Notice of Restricted Stock Unit Award
12/34/56